JTL 0.00% 0.1¢ jayex technology limited

Ann: December 2023 Quarterly Update and Appendix 4C, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 10,917 Posts.
    lightbulb Created with Sketch. 45
    Had a look at the figures in particular sales.
    They have only recently employed a further 2 Business development managers(Salesman) in the last 3 months giving 3 in total. So will take time for the new Salesman to find their feet.
    The bookings for hardware for the quarter Dec 23 was $308k which was up from $239k or 28% which was promising.
    Qualified opportunities at Dec 23 was 347k compared to Sep 23 260k up 33% also promising.
    New licences YTD Dec 23 - 510 YTD Sep 23- 470 up 8.5%.

    Also in cashflow it was quoted -
    "The reduction in operating expenses and growth in sales is expected to
    generate a positive net cash flow ".

    They have entered into the agreement with Morph Clinical to further expand product lines and obtained a loan facility from NAB so they are looking to the future.

    Overall the next 3-6 months will tell how they are tracking especially in sales.
 
watchlist Created with Sketch. Add JTL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.